XWELL, Inc. (XWEL)
NASDAQ: XWEL · Real-Time Price · USD
0.3240
+0.0010 (0.31%)
At close: Jan 28, 2026, 4:00 PM EST
0.3230
-0.0010 (-0.31%)
Pre-market: Jan 29, 2026, 6:12 AM EST

XWELL Revenue

XWELL had revenue of $7.35M in the quarter ending September 30, 2025, a decrease of -12.79%. This brings the company's revenue in the last twelve months to $29.52M, down -12.74% year-over-year. In the year 2024, XWELL had annual revenue of $33.90M with 12.58% growth.

Revenue (ttm)
$29.52M
Revenue Growth
-12.74%
P/S Ratio
0.06
Revenue / Employee
$94,625
Employees
312
Market Cap
1.87M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202433.90M3.79M12.58%
Dec 31, 202330.11M-25.83M-46.18%
Dec 31, 202255.94M-17.79M-24.13%
Dec 31, 202173.73M65.34M779.30%
Dec 31, 20208.39M-40.13M-82.72%
Dec 31, 201948.52M-1.58M-3.15%
Dec 31, 201850.09M1.27M2.60%
Dec 31, 201748.82M36.84M307.33%
Dec 31, 201611.99M-10.70M-47.17%
Dec 31, 201522.69M21.26M1,492.07%
Dec 31, 20141.43M325.00K29.55%
Dec 31, 20131.10M1.00M1,000.00%
Dec 31, 2012100.00K-618.00K-86.07%
Dec 31, 2011718.00K507.00K240.28%
Dec 31, 2010211.00K191.00K955.00%
Dec 31, 200920.00K--
Dec 31, 2008---
Dec 31, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Inotiv513.02M
FONAR105.43M
Biodesix80.17M
Exagen63.60M
Precipio22.80M
bioAffinity Technologies6.78M
iSpecimen3.35M
Mainz Biomed659.94K
Revenue Rankings